Translational Stroke Research of the Combination of Thrombolysis and Antioxidant Therapy

Influence of Recanalization on Uric Acid Patterns in Acute Ischemic Stroke

(2010) Ji Man Hong et al.   CEREBROVASCULAR DISEASES

A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?

(2010) Paul A Lapchak   EXPERT OPINION ON PHARMACOTHERAPY

The Urico-Ictus Study, a Phase 3 Study of Combined Treatment with Uric Acid and rtPA Administered Intravenously in Acute Ischaemic Stroke Patients within the First 4.5 H of Onset of Symptoms

(2010) Sergio Amaro et al.   International Journal of Stroke

The Contribution of L-Arginine to the Neurotoxicity of Recombinant Tissue Plasminogen Activator following Cerebral Ischemia: A Review of rtPA Neurotoxicity

(2010) George WJ Harston et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

(2010) Kennedy R Lees et al.   LANCET

Efficacy of Intra-Arterial Fibrinolysis for Acute Ischemic Stroke

(2010) Meng Lee et al.   STROKE

Oxidative Stress After Thrombolysis-Induced Reperfusion in Human Stroke

(2010) Carmen Domínguez et al.   STROKE

Uric Acid Levels Are Relevant in Patients With Stroke Treated With Thrombolysis

(2010) S. Amaro et al.   STROKE

Stroke Biomarkers: Progress and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment

(2009) A. K. Saenger et al.   CLINICAL CHEMISTRY

Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke

(2009) Sergio Amaro et al.   JOURNAL OF NEUROLOGY

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

(2009) Erich Bluhmki et al.   LANCET NEUROLOGY

Blood Markers for the Prognosis of Ischemic Stroke

(2009) William Whiteley et al.   STROKE

Blood–Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9

(2009) Taura L. Barr et al.   STROKE

Antioxidative and thrombolytic TMP nitrone for treatment of ischemic stroke

(2008) Yewei Sun et al.   BIOORGANIC & MEDICINAL CHEMISTRY

The lipophilic multifunctional antioxidant edaravone (radicut) improves behavior following embolic strokes in rabbits: A combination therapy study with tissue plasminogen activator

(2008) Paul A. Lapchak et al.   EXPERIMENTAL NEUROLOGY

Uric acid administration in patients with acute stroke: a novel approach to neuroprotection

(2008) Sergio Amaro et al.   Expert Review of Neurotherapeutics

Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke

(2008) Enming J Su et al.   NATURE MEDICINE

NXY-059 for the Treatment of Acute Stroke

(2008) Hans-Christoph Diener et al.   STROKE

Oxidative Stress and Matrix Metalloproteinase-9 in Acute Ischemic Stroke

(2007) Peter J. Kelly et al.   STROKE